Blunted lipolytic response to fasting in abdominally obese women: Evidence for involvement of hyposomatotropism

American Journal of Clinical Nutrition

Volumn 77, Issue 3, 2003, Pages 544-550

  Buijs, Madelon M ^a   Burggraaf, Jacobus ^a   Wijbrandts, Carla ^a   De Kam, Marieke L ^a   Frölich, Marijke ^a   Cohen, Adam F ^a   Romijn, Johannes A ^a   Sauerwein, Hans P ^b   Meinders, A Edo ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Lipid metabolism; Lipolysis rate; Obesity; Somatotropin; Starvation; Women

Indexed keywords

CATECHOLAMINE; GLYCEROL; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; GLYCEROL BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; NEUROENDOCRINE SYSTEM; OBESITY; PATHOPHYSIOLOGY; URINARY EXCRETION;

EID: 0037369597     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.3.544     Document Type: Article

References (45)

1. Wolfe RR, Peters EJ, Klein S, Holland OB, Rosenblatt J, Gary H Jr. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol 1987;252:E189-96.
2. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol 1999;276:E278-84.
3. Klein S, Wolfe RR. Carbohydrate restriction regulates the adaptive response to fasting. Am J Physiol 1992;262:E631-6.
4. Saudek CD, Felig P, Cahill GF Jr, et al. The metabolic events of starvation. Am J Med 1976;60:117-26.
5. Klein S, Young VR, Blackburn GL, Bistrian BR, Wolfe RR. Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects. J Clin Invest 1986;78:928-33.
6. Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 1999;23(suppl):10-3.
7. Jensen MD, Haymond MW, Gerich JE, Cryer PE, Miles JM. Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest 1987;79:207-13.
8. Ottosson M, Lonnroth P, Bjorntorp P, Eden S. Effects of cortisol and growth hormone on lipolysis in human adipose tissue. J Clin Endocrinol Metab 2000;85:799-803.
9. Marcus C, Margery V, Kamel A, Bronnegard M. Effects of growth hormone on lipolysis in humans. Acta Paediatr Suppl 1994;406:54-8.
10. Richelsen B. Action of growth hormone in adipose tissue. Horm Res 1997;48(suppl):105-10.
11. Dietz J, Schwartz J. Growth hormone alters lipolysis and hormone-sensitive lipase activity in 3T3-F442A adipocytes. Metabolism 1991;40:800-6.
12. Samra JS, Clark ML, Humphreys SM, Macdonald IA, Matthews DR, Frayn KN. Effects of morning rise in cortisol concentration on regulation of lipolysis in subcutaneous adipose tissue. Am J Physiol 1996;271:E996-1002.
13. Boyle PJ, Avogaro A, Smith L, et al. Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans. Am J Physiol 1992;263:E168-72.
14. Pijl H, Langendonk JG, Burggraaf J, et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab 2001;86:5509-15.
15. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000;62:413-37.
16. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem 1999;274:17541-4.
17. Abumrad NN, Rabin D, Diamond MP, Lacy WW. Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 1981;30:936-40.
18. Heijligenberg R, Romijn JA, Klein S, Endert E, Sauerwein HP. Lipolytic sensitivity to catecholamines in patients with human immunodeficiency virus infection. Am J Clin Nutr 1997;66: 633-8.
19. Simonson DC, DeFronzo RA. Indirect calorimetry: methodological and interpretative problems. Am J Physiol 1990;258:E399-412.
20. Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997;27:210-28.
21. Ackermans MT, Ruiter AF, Endert E. Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography/mass spectrometry. Anal Biochem 1998;258:80-6.
22. Wegman EJ, Wright IW. Splines in statistics. J Am Statist Assoc 1983;78:351-65.
23. Jensen MD, Heiling V, Miles JM. Measurement of non-steady-state free fatty acid turnover. Am J Physiol 1990;258:E103-8.
24. Rosenblatt J, Wolfe RR. Calculation of substrate flux using stable isotopes. Am J Physiol 1988;254:E526-31.
25. Sheng HP, Huggins RA. A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 1979;32:630-47.
26. Gastaldelli A, Coggan AR, Wolfe RR. Assessment of methods for improving tracer estimation of non-steady-state rate of appearance. J Appl Physiol 1999;87:1813-22.
27. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, et al. Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997;100:2858-64.
28. Clutter WE, Bier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest 1980;66:94-101.
29. Watt PW, Finley E, Cork S, Clegg RA, Vernon RG. Chronic control of the beta- and alpha 2-adrenergic systems of sheep adipose tissue by growth hormone and insulin. Biochem J 1991;273:39-42.
30. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994;93:2590-9.
31. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J obese/obese) mice. Mol Endocrinol 1994;8:518-27.
32. Horowitz JF, Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol 2000;278:E1144-52.
33. Galster AD, Clutter WE, Cryer PE, Collins JA, Bier DM. Epinephrine plasma thresholds for lipolytic effects in man: measurements of fatty acid transport with [1-13C]palmitic acid. J Clin Invest 1981;67:1729-38.
34. Yang S, Bjorntorp P, Liu X, Eden S. Growth hormone treatment of hypophysectomized rats increases catecholamine-induced lipolysis and the number of beta-adrenergic receptors in adipocytes: no differences in the effects of growth hormone on different fat depots. Obes Res 1996;4:471-8.
35. Velohuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991;72:51-9.
36. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol 1997;272:E1108-16.
37. Cersosimo E, Danou F, Persson M, Miles JM. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. Am J Physiol 1996;271:E123-6.
38. Klein S, Holland OB, Wolfe RR. Importance of blood glucose concentration in regulating lipolysis during fasting in humans. Am J Physiol 1990;258:E32-9.
39. Ho KY, Veldhuis JD, Johnson ML, et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 1988;81:968-75.
40. Procopio M, Maccario M, Grottoli S, et al. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin Endocrinol (Oxf) 1995;43:665-9.
41. Riedel M, Hoeft B, Blum WF, von zur Muhlen A, Brabant G. Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism 1995;44:605-10.
42. Berneis K, Keller U. Metabolic actions of growth hormone: direct and indirect. Baillieres Clin Endocrinol Metab 1996;10:337-52.
43. Bjorklund A, Yaney G, McGarry JD, Weir G. Fatty acids and beta-cell function. Diabetologia 1997;40:B21-6.
44. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995;44:863-70.
45. Benthem L, Keizer K, Wiegman CH, et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol Endocrinol Metab 2000;279:E1286-93.